Yamada Takahiro, Kimura Yuichi, Watanabe Shogo, Watanabe Aya, Honda Misa, Nagaoka Takashi, Nemoto Mitsutaka, Hanaoka Kohei, Kaida Hayato, Kojita Yasuyuki, Yamada Minoru, Im SungWoon, Kono Atsushi, Ishii Kazunari
Division of Positron Emission Tomography Institute of Advanced Clinical Medicine, Kindai University Hospital, 377-2 Ohno-Higashi, Osakasayama, Osaka, 589-8511, Japan.
Graduate School of Science and Engineering, Kindai University, Osaka, Japan.
Jpn J Radiol. 2025 May 2. doi: 10.1007/s11604-025-01789-3.
Since the approval of disease-modifying drugs for Alzheimer's disease, the demand for amyloid positron emission tomography (PET) scans, which are crucial for determining treatment eligibility, is expected to increase significantly. We thus investigated the ability of an algorithm to predict amyloid accumulation from F-fluorodeoxyglucose (FDG)-PET images for use in amyloid PET screening.
We analyzed the images of 194 subjects with cognitive disorders who had undergone brain FDG-PET, amyloid PET using Pittsburgh compound-B (C-PiB), and MRI scans at Kindai University Hospital between 2011 and 2018. Among them, 108 subjects showed positive amyloid accumulation; the other 86 did not. For the 108 positive cases, the input values were the region of interest-based calculated from the automatic anatomical labeling template, which divides the brain into 120 regions, and applied to the anatomically standardized FDG-PET images of each subject. We then used a support vector machine (SVM) machine learning algorithm and conducted a tenfold cross-validation to assess the algorithm's accuracy for predicting amyloid accumulation from FDG-PET images.
We observed 81.5% accuracy, 78.5% sensitivity, 84.6% specificity, and an area under the curve (AUC) of 0.846 during training. The validation results for the trained model revealed 85.9% accuracy, 88.4% sensitivity, 81.0% specificity, and an AUC of 0.918.
These results indicate that the performance of our algorithm to predict amyloid accumulation from FDG-PET images is adequate for use in amyloid PET scan screenings.
自从用于治疗阿尔茨海默病的疾病修饰药物获批以来,对于淀粉样蛋白正电子发射断层扫描(PET)的需求预计将显著增加,而这种扫描对于确定治疗资格至关重要。因此,我们研究了一种算法从氟脱氧葡萄糖(FDG)-PET图像预测淀粉样蛋白积累的能力,以用于淀粉样蛋白PET筛查。
我们分析了2011年至2018年间在近畿大学医院接受脑部FDG-PET、使用匹兹堡化合物B(C-PiB)进行的淀粉样蛋白PET以及MRI扫描的194名认知障碍患者的图像。其中,108名患者显示淀粉样蛋白积累呈阳性;另外86名患者则未显示。对于108例阳性病例,输入值是基于自动解剖标记模板计算得出的感兴趣区域,该模板将大脑分为120个区域,并应用于每个受试者经解剖标准化的FDG-PET图像。然后,我们使用支持向量机(SVM)机器学习算法并进行了十折交叉验证,以评估该算法从FDG-PET图像预测淀粉样蛋白积累的准确性。
在训练过程中,我们观察到准确率为81.5%,灵敏度为78.5%,特异性为84.6%,曲线下面积(AUC)为0.846。训练模型的验证结果显示准确率为85.9%,灵敏度为88.4%,特异性为81.0%,AUC为0.918。
这些结果表明,我们的算法从FDG-PET图像预测淀粉样蛋白积累的性能足以用于淀粉样蛋白PET扫描筛查。